logo

Chembio Diagnostics Inc (CEMI)



Trade CEMI now with
  Date
  Headline
7/18/2019 8:07:18 AM Chembio Diagnostics And Takeda Pharma Enter Collaboration To Develop Point-of-Care Diagnostic Test
4/9/2019 8:15:28 AM Chembio Diagnostics Announces Approval Of Zika, Dengue And Chikungunya Point-of-Care Multiplex Test By ANVISA
2/6/2019 7:34:27 AM Chembio Diagnostics Sees Q4 Revenue To Be Between $7.3 Mln And $7.6 Mln
11/1/2018 7:22:48 AM Chembio Diagnostics Announces Pricing Of Public Offering Of 2.37 Mln Common Stock At $6.75/Shr
10/22/2018 5:28:17 PM Chembio Diagnostics Begins Public Offering Of $25 Mln Of Common Stock
10/16/2018 7:10:06 AM Chembio Diagnostics Receives $10.5 Mln Commitment From Bio-Manguinhos For Production Of DPP Assays In Brazil
8/8/2018 4:14:05 PM Chembio Diagnostics Appoints Mary Lake Polan To Its Board Of Directors
7/28/2018 9:46:25 AM Chembio Diagnostics Announces Collaboration With FIND To Develop Hepatitis C Virus Point-of-Care Diagnostic Test
7/19/2018 8:08:07 AM Chembio Diagnostics Appoints Christine Rousseau VP, Corporate Development
5/22/2018 8:11:18 AM Chembio Diagnostics And Massachusetts General Hospital Enter MoU To Develop Point-of-Care Fever Diagnostic Test
4/25/2018 8:13:16 AM Chembio Diagnostics, LumiraDx Enter Collaboration To Develop New Point-of-Care Diagnostic Tests For Infectious Diseases
2/9/2018 7:06:46 AM Chembio Diagnostics Announces Pricing Of Public Offering Of 1.78 Mln Shares At $6.75/Shr
  
 
>